Overview:
WSSV, of
the genus Whispovirus, is one of the
most threatening infectious pathogens to the shrimp culture industry, meaning
that any means of treating of vaccinating against this virus would be
incredibly well received. WSSV usually has a mortality rate of 100% over a
period of 2 to 5 days. Currently, no effective vaccines or adequate treatments
are available. It is known to be difficult to vaccinate invertebrates due to
the lack of a true adaptive immune response. Inverts rely solely on an innate
immune response. It has been proved that a quasi-immune response exists which
survives after exposure to the WSSV virus, creating some hope in the field.VP28
is one of five major structural proteins found in WSSV and studies show this
protein is associated with the virion envelope. It is thought to be responsible
for the initial viral infection. The authors of this experiment (Musthaq and Kwang),
by inserting VP28 into a baculovirus, managed to get a VP28 protein expressed
on the surface and use this as a method of VP28-based recombinant vaccination. This
recombinant vaccine was named Bac-VP28. A construct that did not have the VP28
gene was termed Bac-wt. The amount of VP28 present in Bac-VP28 was measured as
65.3micrograms per ml and considered as an abundant quantity.
Oral Vaccination Results:
Shrimp were
orally administered Bac-VP28, Bac-wt and PBS respectively (groups 1-3).
Bac-VP28 and Bac-wt coated feed was administered continuously for 7 days before
the shrimp were subsequently challenged with the WSSV. Batch 1 and 2 were
treated identically, except batch 1 received a WSSV dose of 3dpv and batch 2
received a dose of 15dpv.
In all
cases, the positive control group (3) showed 100% mortality, as did group 2,
treated with the Bac-wt. The group (1) treated with Bac-VP28 however showed
only an 18.3% (batch1) and 23.3% (batch2) mortality rate, which is
significantly reduced.
A negative
control group (without the virus) showed no mortality.
Immersion Vaccination Results:
As with the
oral vaccination, there were the 3 groups, Bac-VP28 (1), Bac-wt (2) and PBS
(3). Instead of through feed, they were vaccinated through immersion in a solution.
Again, all shrimps in batch 1 were challenged with WSSV at 3dpv and those in
batch 2 challenge with WSSV at 15dpv.
All of
group 2 (Bac-wt) and 3 (PBS) showed 100% mortality, yet those treated in group
1 (Bac-VP28) showed a mortality rate of only 25% (batch1) and 31.6% (batch2).
This was a significant decrease in mortality rate.
Summary
Syed MS, Kwang J (2011) Oral vaccination of baculovirus-expressed VP28 displays enhanced protection against White Spot Syndrome Virus in Penaeus monodon. PLOS ONE 6: e26428.10.1371/journal.pone.0026428 PubMed: 22069450.